Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05286801 |
|---|---|
| Brief Title: | Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors |
| First Submitted : | March 15, 2022 |
| First Submitted that Met QC Criteria : | March 15, 2022 |
| First Posted : | March 18, 2022 |
| Last Update Submitted that Met QC Criteria : | May 15, 2024 |
| Last Update Posted : | May 16, 2024 |